Physician profile
Rodney Vitovsky
NPI 1619912581
$1,718.54
in general payments reported to CMS, 2019-2025
10 companies · $515 in 2025
The $515 reported for 2025 was more than what 80% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.34 · 2022: $1,088 · 2023: $103 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $932.20 | 2022 | |
| Ebi, LLC | $249.65 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $249.65 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Medtronic, INC. | $183.03 | 2022-2023 | Catalyft Pl Expandable Interbody System |
| Stryker Corporation | $24.38 | 2022 | |
| Nevro Corp. | $23.70 | 2022 | |
| Inspiremd LTD | $15.28 | 2025 | Cguard Prime Carotid Stent System |
| Livanova USA, INC. | $14.80 | 2022 | |
| Depuy Synthes Sales INC. | $13.51 | 2022 | |
| Boston Scientific Corporation | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Vitovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.